Please assess the completion status of the following clinical trial:

Trial Title: Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically or cytologically confirmed metastatic (stage IV) NSCLC with no significant pleural effusion or pleural involvement from the tumor~* Age greater than or equal to 18 years~* Adequate organ and bone marrow function~Exclusion Criteria:~* Any prior systemic therapy for NSCLC~* Major surgical procedure or other investigational agents within 4 weeks before study enrollment~* Need for concomitant use of other thiazolidinediones during the study~* History of any of the following conditions within 6 months prior to initiating study treatment: Diabetes mellitus requiring treatment with insulin or sulfonylureas or thiazolidinediones (TZDs) agents; Myocardia infarction with significant impairment of cardia function; Malabsorption syndrome, chronic diarrhea, inflammatory bowel disease or partial bowel obstruction;~* Clinically active brain metastases, uncontrolled seizure disorder; spinal cord compression or carcinomatous meningitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CS-7017 with Paclitaxel and Carboplatin (Type: EXPERIMENTAL): None
- Paclitaxel and Carboplatin (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).